Company Perspective Therapeutics, Inc.
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.185 USD | -1.25% | -11.57% | +194.78% |
12:30pm | Perspective Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 26 | North American Morning Briefing : Markets Steady -2- | DJ |
Business Summary
Number of employees: 91
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Prostate Brachytheraphy
74.7
%
| 8 | 77.8 % | 8 | 74.7 % | +3.02% |
Other
25.3
%
| 2 | 22.2 % | 3 | 25.3 % | +22.70% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 10 | 100.0 % | 11 | 100.0 % | +7.43% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 585,322,904 | 404,560,568 ( 69.12 %) | 0 | 69.12 % |
Company contact information
Perspective Therapeutics, Inc.
2401 Elliott Avenue Suite 320
98121, Seattle
+
http://perspectivetherapeutics.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+194.78% | 704M | |
+3.43% | 197B | |
+5.96% | 115B | |
+1.75% | 71.22B | |
+12.17% | 53.77B | |
+18.06% | 48.75B | |
+6.87% | 44.22B | |
+12.44% | 28.85B | |
+10.23% | 28.57B | |
+10.35% | 27.62B |
- Stock
- Equities
- Stock Perspective Therapeutics, Inc. - Nyse
- Company Perspective Therapeutics, Inc.